Vyome Therapeutics Inc.
www.vyometx.comVyome Therapeutics Inc. is an innovation driven drug development company, with a vision to develop novel drugs for immune-inflammation diseases that can be treated through local administrated agents. Vyome's management team members are the leaders in the field, with deep expertise, demonstrated capability and a proven track record of successfully launching over 50 products in dermatology & other life sciences areas, and building visionary companies. Vyome’s development platform is completely risk mitigated. Vyome has a deep pipeline of IP based products targeting multiple indications. The lead molecule (VB 1953), which targets the huge unmet need in the drug resistant acne prescription market, is currently being evaluated in clinical trials in the United States. Vyome has state-of-the-art infrastructure to carry out all its research and lab development work, with full-fledged formulation, analytical, chemistry, biology & molecular biology, clinical and the regulatory divisions. The infrastructure and the team enables Vyome to conceive ideas, develop them and commercialize them at a rapid pace.
Read moreVyome Therapeutics Inc. is an innovation driven drug development company, with a vision to develop novel drugs for immune-inflammation diseases that can be treated through local administrated agents. Vyome's management team members are the leaders in the field, with deep expertise, demonstrated capability and a proven track record of successfully launching over 50 products in dermatology & other life sciences areas, and building visionary companies. Vyome’s development platform is completely risk mitigated. Vyome has a deep pipeline of IP based products targeting multiple indications. The lead molecule (VB 1953), which targets the huge unmet need in the drug resistant acne prescription market, is currently being evaluated in clinical trials in the United States. Vyome has state-of-the-art infrastructure to carry out all its research and lab development work, with full-fledged formulation, analytical, chemistry, biology & molecular biology, clinical and the regulatory divisions. The infrastructure and the team enables Vyome to conceive ideas, develop them and commercialize them at a rapid pace.
Read moreCountry
State
New Jersey
City (Headquarters)
Princeton
Industry
Employees
11-50
Founded
2010
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Associate Vice President
Email ****** @****.comPhone (***) ****-****Co - Founder
Email ****** @****.comPhone (***) ****-****Co - Founder
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****
Technologies
(6)